Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Blackstone stories

Nov 11, 2026

Pfizer secures up to $1.5 billion from Blackstone for obesity drug development

Pfizer has struck a deal with Blackstone to receive up to $1.5 billion through 2028 to fund development of an experimental monthly obesity treatment, as the company races to compete in the GLP-1 market without a currently approved weight-loss drug.

Nov 11, 2026·3 sources
00
Nov 7, 2026

Crusoe sells Wyoming data center project to Google

Denver-based data center developer Crusoe, valued at $30.9 billion, confirmed it sold an unfinished data center project in southeastern Wyoming to Google. This connects to Google's previously announced $17 billion Wyoming data center investment.

Nov 7, 2026·4 sources
00
Nov 5, 2026

Shield AI raises $2.5 billion to acquire radar maker Echodyne for $5.3 billion

Defense AI contractor Shield AI is raising $2.5 billion in new funding to acquire radar provider Echodyne for $5.3 billion, valuing Shield AI at $28.8 billion.

Nov 5, 2026·2 sources
00
Nov 3, 2026

Traversal raises $120 million at $1 billion valuation for autonomous site reliability engineering

Traversal Inc., a startup automating site reliability engineering with AI, has raised $120 million in funding at a $1 billion valuation.

Nov 3, 2026·2 sources
00
Jul 15, 2026

Anthropic, Blackstone, and Hellman & Friedman officially launch Ode, $1.5B AI enterprise services firm

Launched on July 15, 2026, Ode with Anthropic is a $1.5 billion enterprise AI services firm backed by Anthropic, Blackstone, Hellman & Friedman, Goldman Sachs, and others, built on the acquisition of Fractional AI to deploy engineers directly into mid-sized companies.

Jul 15, 2026·5 sources
00

Top claims

  • ▪In 2024, Blackstone Inc. reached an agreement to fund trials for Moderna Inc.’s influenza vaccine, which subsequently received U.S. regulatory approval in summer 2026
  • ▪Pfizer Inc. will maintain full ownership and operational control over the clinical development program for berobenatide under its funding deal with Blackstone Inc.
  • ▪Blackstone Inc. has expanded its involvement in co-funding clinical drug development trials in recent years

Topics

Clinical trialsWeight loss drugsGLP-1 receptor agonistsDrug developmentGLP-1Pharmaceutical IndustryPrivate equityObesity treatmentAI data centersAI Data Center Gold RushMicrosoftAI investmentTexasOpenAICompute, chips & AI infrastructureMetaMilitary AIAutonomous weaponsAI startupsAI IndustryVenture capital fundingAI companies founding roundsBusiness & enterprise AIAI applicationsAI agentsAI tools & products

Related entities

OracleUnited StatesDenverAmarilloWyomingIndiaTaiwanNubankKhosla VenturesSequoia CapitalEddie SiegelLeonard Green & Partners